ULTRASTRUCTURAL AND IMMUNOCYTOCHEMICAL ASPECTS OF LYMPHOCYTIC SUBMANDIBULITIS IN THE NONOBESE DIABETIC (NOD) MOUSE

被引：71

作者：

MIYAGAWA, J

HANAFUSA, T

MIYAZAKI, A

YAMADA, K

FUJINOKURIHARA, H

NAKAJIMA, H

KONO, N

NONAKA, K

TOCHINO, Y

TARUI, S

机构：

[1] KURUME UNIV,SCH MED,DEPT MED,DIV ENDOCRINOL & METAB,KURUME,FUKUOKA 830,JAPAN

[2] SHIONOGI & CO LTD,SHIONOGI RES LAB,FUKUSHIMA KU,OSAKA 553,JAPAN

来源：

VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY | 1986年 / 51卷 / 03期

关键词：

D O I：

10.1007/BF02899031

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

收藏

页码：215 / 225

页数：11

相关论文

共 26 条

[1] SALIVARY-GLAND IMMUNOGLOBULIN AND RHEUMATOID-FACTOR SYNTHESIS IN SJOGRENS SYNDROME - NATURAL-HISTORY AND RESPONSE TO TREATMENT
ANDERSON, LG
ASOFSKY, R
HYLTON, MB
SCHALL, GL
TOMASI, TB
TALAL, N
TARPLEY, TM
WOLF, RO
CUMMINGS, NA
[J]. AMERICAN JOURNAL OF MEDICINE, 1972, 53 (04) : 456 - &
[2] RELAXING EFFECTS OF BETA-RECEPTOR STIMULATORS IN ISOLATED, GRAVID HUMAN MYOMETRIUM
ANDERSSON, KE
INGEMARSSON, I
PERSSON, CGA
[J]. LIFE SCIENCES, 1973, 13 (04) : 335 - 344
[3] ASAMOTO H, 1984, Journal of the Japan Diabetes Society, V27, P775
[4] SJOGRENS SYNDROME AND ITS RELATION TO CONNECTIVE TISSUE DISEASES
BLOCH, KJ
BUNIM, JJ
[J]. JOURNAL OF CHRONIC DISEASES, 1963, 16 (08): : 915 - +
[5] BOUQUIST L, 1970, ACTA OTOLARYNGOL, V70, P216
[6] PERSISTENT CYTOMEGALOVIRUS-INFECTION - THE ETIOLOGY OF SJOGRENS SYNDROME
BURNS, JC
[J]. MEDICAL HYPOTHESES, 1983, 10 (04) : 451 - 460
[7] LABIAL SALIVARY GLAND BIOPSY IN SJOGRENS DISEASE
CHISHOLM, DM
MASON, DK
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1968, 21 (05) : 656 - &
[8] LYMPHOCYTIC SIALADENITIS IN MAJOR AND MINOR GLANDS - A CORRELATION IN POSTMORTEM SUBJECTS
CHISHOLM, DM
WATERHOUSE, JP
MASON, DK
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1970, 23 (08) : 690 - +
[9] TUBULORETICULAR STRUCTURES WITHIN LABIAL SALIVARY-GLANDS IN SJOGRENS SYNDROME
DANIELS, TE
SYLVESTER, RA
SILVERMAN, S
POLANDO, V
TALAL, N
[J]. ARTHRITIS AND RHEUMATISM, 1974, 17 (05): : 593 - 597
[10] FELTKAMP T. E. W., 1968, CLIN EXP IMMUNOL, V3, P1